Stay updated on CAB-AXL-ADC in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.

Latest updates to the CAB-AXL-ADC in Sarcoma Clinical Trial page
- Check3 days agoChange DetectedThe study record now shows updated dates (Primary Completion Actual 2025-01-08; Study Completion Actual 2025-01-08) and the latest Last Update Posted date, with enrollment listed as 245 across sites.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check32 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%

- Check39 days agoChange DetectedPage updates reflect a versioned metadata refresh (e.g., Revision: v3.1.0) and date stamps, replacing older items (e.g., Revision: v3.0.2) and removing an outdated resource note. Overall, there is no significant change to core content or critical data.SummaryDifference2%

- Check53 days agoChange DetectedRevision bumped from v3.0.1 to v3.0.2; the 'Back to Top' link has been removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has added specific resources related to genetic and rare diseases, including information on various types of sarcomas and cancer topics, while also updating the facility name and locations. Notably, some previously listed locations and terms have been removed.SummaryDifference5%

Stay in the know with updates to CAB-AXL-ADC in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.